These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 34533119)
21. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination. Yang W; Shaman J medRxiv; 2021 Nov; ():. PubMed ID: 34845460 [TBL] [Abstract][Full Text] [Related]
28. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140 [TBL] [Abstract][Full Text] [Related]
29. Active viral shedding in a vaccinated hospitalized patient infected with the delta variant (B.1.617.2) of SARS-CoV-2 and challenges of de-isolation. Alshukairi AN; Al-Omari A; Al-Tawfiq JA; El-Kafrawy SA; El-Daly MM; Hassan AM; Faizo AA; Alandijany TA; Dada A; Saeedi MF; Alhamlan FS; Al Hroub MK; Qushmaq I; Azhar EI J Infect Public Health; 2022 Jun; 15(6):628-630. PubMed ID: 35576779 [TBL] [Abstract][Full Text] [Related]
30. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study. Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P; PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956 [TBL] [Abstract][Full Text] [Related]
31. Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients. Deng X; Evdokimova M; O'Brien A; Rowe CL; Clark NM; Harrington A; Reid GE; Uprichard SL; Baker SC Viruses; 2021 Sep; 13(9):. PubMed ID: 34578324 [TBL] [Abstract][Full Text] [Related]
32. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study. Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541 [TBL] [Abstract][Full Text] [Related]
33. Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study. Lin Y; Wu P; Tsang TK; Wong JY; Lau EHY; Yang B; Leung GM; Cowling BJ Lancet Microbe; 2023 Sep; 4(9):e722-e731. PubMed ID: 37659420 [TBL] [Abstract][Full Text] [Related]
34. Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals. Caserta LC; Martins M; Cronk B; Anderson R; Eldridge H; Gallow D; Kruppa F; Plocharczyk E; Diel DG Microbiol Spectr; 2022 Oct; 10(5):e0056322. PubMed ID: 36165775 [TBL] [Abstract][Full Text] [Related]
35. Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals. Huai Luo C; Paul Morris C; Sachithanandham J; Amadi A; Gaston DC; Li M; Swanson NJ; Schwartz M; Klein EY; Pekosz A; Mostafa HH Clin Infect Dis; 2022 Aug; 75(1):e715-e725. PubMed ID: 34922338 [TBL] [Abstract][Full Text] [Related]
36. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021. Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630 [TBL] [Abstract][Full Text] [Related]
37. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds. Lee BU Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574724 [TBL] [Abstract][Full Text] [Related]
39. Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections. Zou J; Xie X; Liu M; Shi PY; Ren P mBio; 2022 Aug; 13(4):e0199622. PubMed ID: 35924850 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 Vaccines Among US Military Personnel Before and During the Predominance of the Delta Variant. Eick-Cost AA; Ying S; Wells N JAMA Netw Open; 2022 Apr; 5(4):e228071. PubMed ID: 35442453 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]